Crucial medicine at risk of running out in Hungary

Hungary is on the brink of a healthcare crisis as an essential medicine, insulin, is at risk of running out. In a letter addressed to Hungarian General Practitioners (GPs), the State Secretary for Health, Dr. Péter Takács, warned that disruptions in insulin supply are likely to occur starting in July.

The letter was later shared on social media by pharmacist Dr Szabolcs Dobson. It advises doctors to proactively communicate with nearby pharmacies to determine the availability of specific medications. Furthermore, it proposes that GPs seek suitable alternatives for their patients, writes Pénzcentrum.

Huge shortage

Manufacturing problems and market considerations are believed to be the primary factors contributing to this alarming situation.

Dated 26 June, Dr Takács’ letter explicitly states:

“From 1 July 2023, the availability of certain human insulin products will change. Considering that the recommendations provided by specialists are applicable to all human insulin products, regardless of the specific product mentioned in the recommendation, I urge you to contact your nearest pharmacy to inquire about the availability of human insulin products before prescribing a specific medicine. A new specialist recommendation is not required, and any available insulin product from any manufacturer can be prescribed based on the current recommendation.”